Comparison 4. MIB vs. control: maternal outcomes.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Positive urine drug test (end of treatment) | 2 | 278 | Risk Ratio (M‐H, Random, 95% CI) | 0.96 [0.63, 1.48] |
2 Positive urine drug test at three months (follow‐up) | 1 | 159 | Risk Ratio (M‐H, Random, 95% CI) | 1.13 [0.55, 2.31] |
3 Positive urine at delivery | 1 | 128 | Risk Ratio (M‐H, Random, 95% CI) | 0.84 [0.57, 1.24] |
4 Retention at treatment completion | 3 | 355 | Risk Ratio (M‐H, Random, 95% CI) | 0.97 [0.89, 1.06] |
5 Short term treatment retention | 3 | 334 | Risk Ratio (M‐H, Random, 95% CI) | 0.99 [0.88, 1.12] |